In 2003, Dr. Omolola Salako watched her younger sister die from advanced kidney cancer.

At the time, Nigeria had roughly 30 clinical oncologists in the entire country. Her sister couldn't reach a single one of them.

She eventually had to be moved to the UK for palliative care, where she passed away in less than three months.

Omolola was a medical professional. She knew what was happening. She also knew there was almost nothing she could do about it.

That kind of helplessness breaks most people. For Omolola, it became the beginning

Purpose Carved Out of Pain

Three years after losing her sister, Dr. Salako went back to the UK, not to mourn but to intern at the same palliative care hospital where her sister had spent her final days.

She described it as resolving an internal conflict. And when she returned to Nigeria, she came back with a plan.

In 2006, she founded Sebeccly Cancer Care and Support Centre, a not-for-profit built to reduce Nigeria's cancer burden through education, advocacy and patient support.

She was making a clear, audible statement. One that said: if the system won't show up for these patients, we will.

Sebeccly has since screened over 20,000 women for cancer and supported more than 2,000 patients. But more importantly, it became the seed from which everything else grew.

One Problem, Many Solutions

Many people would have probably stopped at one organisation but Dr Salako didn't. Because she understood that cancer care in Nigeria isn't just one problem.

It is a cocoon of problems: lack of information, lack of access, lack of proximity, lack of funds. So she built solutions for all of them.

In 2018, she launched Oncopadi Technologies, a digital health platform designed to connect cancer patients with specialists without requiring them to physically travel across the country.

The app allows patients to book virtual consultations, track their symptoms remotely, and access a support community, all from their phones. She called it the "Uber of cancer care."

For a country where most patients only show up to a clinic once cancer has already advanced, having that kind of early digital touchpoint is genuinely lifesaving.

Then in 2021, she took it onsite.

Pearl Oncology Specialist Hospital launched as a full cancer treatment centre in Lagos, offering chemotherapy, surgery, consultations and ward admissions.

It has since expanded to four communities across the state, with a team of over 40 healthcare professionals.

And to round it all out, she developed PROSECare AI, a digital patient monitoring platform that keeps tracking care even after the clinic visit ends.

Four organisations, one vision in 4k and you have a full outlook of an ecosystem.

The Numbers Behind the Crisis

To understand why this work matters, you have to look at the numbers.

Nigeria records over 125,000 new cancer cases annually. More than 78,000 of those people die, a mortality rate of around 63%.

Most of the deaths happen not because treatment doesn't exist, but because patients show up too late, can't afford care or simply can't find a specialist.

Breast cancer treatment alone starts at around N3 million and can climb to N20 million — an amount that would bankrupt most Nigerian families, even the ones who consider themselves comfortable.

Dr. Salako knows this, which is why she and her organisations created the Thank God It's Friday (TGIF) Breast Clinic, a program where Sebeccly, Oncopadi, and Pearl Oncology pool resources to cover 40% of a patient's treatment costs, leaving them to pay roughly what they would spend at a public hospital, but with faster, more personalised care.

It is not a perfect fix. But it keeps people in treatment, which is the whole point.

Recognition That Means Something

The world has taken notice. Dr. Salako was named one of the "Brightest Minds in Cancer Research" by the American Society of Clinical Oncology in 2021, a list that doesn't hand out spots casually.

She is also a recipient of the ASCO International Innovation Grant, the Astellas US Oncology C3 Grand Prize, the 2023 Global Bridges Oncology and Pfizer Global Medical Grant and the Best UICC CEO Award for her leadership at Sebeccly.

She lectures and conducts research at the College of Medicine, University of Lagos, with over 45 peer-reviewed articles to her name.

And she is still one of fewer than 90 clinical oncologists in Nigeria. That number should be disturbing to all of us.

What She's Actually Building

Dr. Omolola Salako is actively trying to change the conditions that make cancer a death sentence for so many Nigerians.

She is training the next generation of oncologists, building the tech infrastructure for digital cancer care, and making the financial case for why access to treatment can't remain a privilege.

She found a purpose in her pain. And she has been building with it ever since.